S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
NASDAQ:AXDX

Accelerate Diagnostics (AXDX) Stock Price, News & Analysis

$3.92
-0.08 (-2.00%)
(As of 12/29/2023 ET)
Today's Range
$3.72
$4.05
50-Day Range
$3.92
$6.38
52-Week Range
$3.72
$11.90
Volume
105,552 shs
Average Volume
46,136 shs
Market Capitalization
$57.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Accelerate Diagnostics MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
5.13% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.62
Upright™ Environmental Score
News Sentiment
1.44mentions of Accelerate Diagnostics in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$8,509 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($4.63) to ($2.03) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.08 out of 5 stars

Medical Sector

549th out of 950 stocks

Analytical Instruments Industry

13th out of 26 stocks


AXDX stock logo

About Accelerate Diagnostics Stock (NASDAQ:AXDX)

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. The company was incorporated in 1982 and is headquartered in Tucson, Arizona.

AXDX Stock Price History

AXDX Stock News Headlines

New Year's Sale: Get MarketBeat All Access Free For 30 Days
Access our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. Click the link to claim your $300.00 account credit and free 30-day subscription
Accelerate Diagnostics Reports Third Quarter 2023 Results
New Year's Sale: Get 12 Months of Stock Picks for $9.00
Gear up for what's happening in the stock market in 2024. Our friends at Behind the Markets are offering an opportunity that is simply too good to pass up - 12-months of their best stock ideas for just $9.00. Don't sleep on this.
Accelerate Diagnostics Reports Second Quarter 2023 Financial Results
See More Headlines
Receive AXDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Accelerate Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/09/2023
Today
12/31/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
4/03/2024

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AXDX
Employees
179
Year Founded
N/A

Profitability

Net Income
$-62,490,000.00
Net Margins
-472.05%
Pretax Margin
-522.81%

Debt

Sales & Book Value

Annual Sales
$12.00 million
Book Value
($2.25) per share

Miscellaneous

Free Float
9,749,000
Market Cap
$57.04 million
Optionable
Optionable
Beta
0.92
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Jack PhillipsMr. Jack Phillips (Age 57)
    CEO, President & Director
    Comp: $595k
  • Mr. Lawrence Michael Mertz (Age 61)
    Chief Technology Officer
    Comp: $329.23k
  • Mr. Steve ReichlingMr. Steve Reichling (Age 45)
    Consultant
    Comp: $349.81k
  • Mr. David Patience (Age 37)
    CFO, Principal Financial Officer & Principal Accounting Officer
  • Ms. Maya Gowri
    Senior VP & Head of Operations
  • Laura Pierson
    Investor Relations Officer
  • Ms. Gretchen Strohminger
    Senior VP and Head of Human Resources & Culture
  • Mr. John Meduri
    Chief Strategy Officer
  • Mr. Kurtis Montegna
    Senior Vice President of Regulatory Affairs & Quality Assurance
  • Mr. Chris Thode
    Senior Vice President of US Commercial














AXDX Stock Analysis - Frequently Asked Questions

How have AXDX shares performed in 2023?

Accelerate Diagnostics' stock was trading at $7.06 at the start of the year. Since then, AXDX stock has decreased by 44.5% and is now trading at $3.92.
View the best growth stocks for 2023 here
.

When is Accelerate Diagnostics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 3rd 2024.
View our AXDX earnings forecast
.

How were Accelerate Diagnostics' earnings last quarter?

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) posted its quarterly earnings data on Thursday, November, 9th. The medical research company reported ($0.92) earnings per share for the quarter, topping the consensus estimate of ($0.94) by $0.02. The medical research company earned $3.30 million during the quarter, compared to the consensus estimate of $3.60 million.

When did Accelerate Diagnostics' stock split?

Shares of Accelerate Diagnostics reverse split on the morning of Wednesday, July 12th 2023. The 1-10 reverse split was announced on Wednesday, July 12th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of Accelerate Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Accelerate Diagnostics investors own include Himax Technologies (HIMX), Magnachip Semiconductor (MX), Fluidigm (FLDM), Universal Display (OLED), Gilead Sciences (GILD), BIOLASE (BIOL), Alibaba Group (BABA), AT&T (T), AbbVie (ABBV) and Micron Technology (MU).

How do I buy shares of Accelerate Diagnostics?

Shares of AXDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AXDX) was last updated on 12/31/2023 by MarketBeat.com Staff

My Account -